Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscle

Metabolism: Clinical and Experimental

Volumn 60, Issue 4, 2011, Pages 491-498

  Evans, Vanessa C ^a   Graham, Ian R ^b   Athanasopoulos, Takis ^b   Galley, Deborah J ^c   Jackson, Christopher L ^c   Simons, Jonathan Paul ^a   Dickson, George ^b   Owen, James S ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; BETA ACTIN; CHOLESTEROL; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRACHIOCEPHALIC TRUNK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HYPERLIPIDEMIA; IMAGE ANALYSIS; LIPID DIET; MOUSE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; TIBIALIS ANTERIOR MUSCLE; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; APOLIPOPROTEIN E3; ATHEROSCLEROSIS; CELL LINE; CEREBRAL ARTERIES; CULTURE MEDIA; DEPENDOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENETIC VECTORS; HUMANS; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; SEROTYPING; TRANSDUCTION, GENETIC;

EID: 79952993788     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.04.015     Document Type: Article

References (57)

1. Harris J.D., Evans V., and Owen J.S. ApoE gene therapy to treat hyperlipidemia and atherosclerosis Curr Opin Mol Ther 8 2006 275 287 (Pubitemid 44256361)
2. Meir K.S., and Leitersdorf E. Atherosclerosis in the apolipoprotein-E- deficient mouse: a decade of progress Arterioscler Thromb Vasc Biol 24 2004 1006 1014 (Pubitemid 38737824)
3. Stevenson S.C., Marshall-Neff J., and Teng B. Phenotypic correction of hypercholesterolemia in apoE-deficient mice by adenovirus-mediated in vivo gene transfer Arterioscler Thromb Vasc Biol 15 1995 479 484
4. Harris J.D., Graham I.R., and Schepelmann S. Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE Hum Mol Genet 11 2002 43 58 (Pubitemid 34100767)
5. Kim I.H., Jozkowicz A., and Piedra P.A. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector Proc Natl Acad Sci U S A 98 2005 13282 13287
6. McCaffrey A.P., Fawcett P., and Nakai H. The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver Mol Ther 16 2008 931 941 (Pubitemid 351587104)
7. Nayak S., and Herzog R.W. Progress and prospects: immune responses to viral vectors Gene Ther 17 2010 295 304
8. Wu Z., Asokan A., and Samulski R.J. Adeno-associated virus serotypes: vector toolkit for human gene therapy Mol Ther 14 2006 316 327 (Pubitemid 44184972)
9. Warrington K.H. Jr, and Herzog R.W. Treatment of human disease by adeno-associated viral gene transfer Hum Genet 119 2006 571 603 (Pubitemid 43805835)
10. Harris J.D., Schepelmann S., and Athanasopoulos T. Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E Gene Ther 9 2002 21 29 (Pubitemid 34145164)
11. Chao H., Liu Y., and Rabinowitz J. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors Mol Ther 2 2000 619 623
12. Gao G.P., Alvira M.R., and Wang L. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy Proc Natl Acad Sci U S A 99 2002 11854 11859 (Pubitemid 34994488)
13. Louboutin J.P., Wang L., and Wilson J.M. Gene transfer into skeletal muscle using novel AAV serotypes J Gene Med 7 2005 442 451 (Pubitemid 40553125)
14. Mori S., Wang L., and Takeuchi T. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein Virology 330 2004 375 383 (Pubitemid 39572844)
15. Schmidt M., Voutetakis A., and Afione S. Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity J Virol 82 2008 1399 1406
16. Penaud-Budloo M., Le Guiner C., and Nowrouzi A. Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle J Virol 82 2008 7875 7885
17. Sun B., Young S.P., and Li P. Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy Mol Ther 16 2008 1366 1371
18. Lu Y., and Song S. Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors Proc Natl Acad Sci U S A 106 2009 17158 17162
19. Zincarelli C., Soltys S., and Rengo G. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection Mol Ther 16 2008 1073 1080 (Pubitemid 351737072)
20. Gao G., Vandenberghe L.H., and Alvira M.R. Clades of adeno-associated viruses are widely disseminated in human tissues J Virol 78 2004 6381 6388 (Pubitemid 38715936)
21. Inagaki K., Fuess S., and Storm T.A. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8 Mol Ther 14 2006 45 53 (Pubitemid 43899488)
22. Pacak C.A., Mah C.S., and Thattaliyath B.D. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo Circ Res 99 2006 e3 e9
23. Boutin S., Monteilhet V., and Veron P. Prevalence of serum IgG and neutralizing factors against adeno-associated virus types 1, 2, 5, 6, 8 and 9 in the healthy population: implications for gene therapy using AAV vectors Hum Gene Ther 2010 [Epub ahead of print]
24. Limberis M.P., and Wilson J.M. Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered Proc Natl Acad Sci U S A 103 2006 12993 12998 (Pubitemid 44338905)
25. Yue Y., and Dongsheng D. Development of multiple cloning site cis-vectors for recombinant adeno-associated virus production Biotechniques 33 2002 672 678 (Pubitemid 35277573)
26. Zolotukhin S., Byrne B.J., and Mason E. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield Gene Ther 6 1999 973 985 (Pubitemid 29295202)
27. Snyder RO, Xiao X, Samulski RJ. Production of recombinant adeno-associated viral vectors. Current protocols in human genetics (John Wiley & Sons) 1996; 12.1.11-15.
28. Johnson J.L., and Jackson C.L. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse Atherosclerosis 154 2001 399 406 (Pubitemid 32146612)
29. Johnson J., Carson K., and Williams H. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment Circulation 111 2005 1422 1430 (Pubitemid 40396809)
30. Thomas C.E., Storm T.A., and Huang Z. Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors J Virol 78 2004 3110 3122 (Pubitemid 38314369)
31. Akache B., Grimm D., and Shen X. A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8 Mol Ther 15 2007 330 339 (Pubitemid 46111883)
32. Plump A.S., Smith J.D., and Hayek T. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells Cell 71 1992 343 353
33. Zhang S.H., Reddick R.L., and Burkey B. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption J Clin Invest 94 1994 937 945 (Pubitemid 24286433)
34. van Ree J.H., Gijbels M.J., and van den Broek W.J. Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding Atherosclerosis 112 1995 237 243
35. Sivak O., Darlington J., and Gershkovich P. Protonated nanostructured aluminosilicate (NSAS) reduces plasma cholesterol concentrations and atherosclerotic lesions in apolipoprotein E deficient mice fed a high cholesterol and high fat diet Lipids Health Dis 8 2009 30
36. Fu T., Kozarsky K.F., and Borensztajn J. Overexpression of SR-BI by adenoviral vector reverses the fibrate induced hypercholesterolemia of apolipoprotein E-deficient mice J Biol Chem 278 2003 52559 52563 (Pubitemid 38035852)
37. Van Eck M., Hoekstra M., and Out R. Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo J Lipid Res 9 2008 136 146
38. Cooper A.D. Hepatic uptake of chylomicron remnants J Lipid Res 38 1997 2173 2192 (Pubitemid 27495377)
39. Thorngate F.E., Rudel L.L., and Walzem R.L. Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice Arterioscler Thromb Vasc Biol 20 2000 1939 1945 (Pubitemid 30644644)
40. Sullivan P.M., Mezdour H., and Aratani Y. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis J Biol Chem 272 1997 17972 17980 (Pubitemid 27306374)
41. Williams H., Johnson J.L., and Carson K.G. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice Arterioscler Thromb Vasc Biol 22 2002 788 792 (Pubitemid 34517790)
42. Virmani R., Kolodgie F.D., and Burke A.P. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 20 2000 1262 1275 (Pubitemid 30262927)
43. Cioffi L., Sturtz F.G., and Wittmer S. A novel endothelial cell-based gene therapy platform for the in vivo delivery of apolipoprotein E Gene Ther 6 1999 1153 1159 (Pubitemid 29295222)
44. Athanasopoulos T., Owen J.S., and Hassall D. Intramuscular injection of a plasmid vector expressing human apolipoprotein E limits progression of xanthoma and aortic atheroma in apoE-deficient mice Hum Mol Genet 9 2000 2545 2551
45. Wientgen H., Thorngate F.E., and Omerhodzic S. Subphysiologic apolipoprotein E (ApoE) plasma levels inhibit neointimal formation after arterial injury in ApoE-deficient mice Arterioscler Thromb Vasc Biol 24 2004 1460 1465 (Pubitemid 39050441)
46. Stannard A.K., Riddell D.R., and Sacre S.M. Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells J Biol Chem 276 2001 46011 46016
47. Ma Y., Malbon C.C., and Williams D.L. Altered gene expression in early atherosclerosis is blocked by low level apolipoprotein E PLoS One e2503 2008 3
48. Bennett B.J., Wang S.S., and Wang X. Genetic regulation of atherosclerotic plaque size and morphology in the innominate artery of hyperlipidemic mice Arterioscler Thromb Vasc Biol 29 2009 348 355
49. Davidoff A.M., Ng C.Y., and Zhou J. Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway Blood 122 2003 480 488 (Pubitemid 36841964)
50. Dane A.P., Cunningham S.C., and Graf N.S. Sexually dimorphic patterns of episomal rAAV genome persistence in the adult mouse liver and correlation with hepatocellular proliferation Mol Ther 17 2009 1548 1554
51. Zaiss A.K., and Muruve D.A. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge Gene Ther 15 2008 808 816 (Pubitemid 351712613)
52. Salva M.Z., Himeda C.L., and Tai P.W. Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle Mol Ther 15 2007 320 329 (Pubitemid 46111882)
53. Li W., Asokan A., and Wu Z. Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles Mol Ther 16 2008 1252 1260 (Pubitemid 351866056)
54. Wu Z., Sun J., and Zhang T. Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose Mol Ther 16 2008 280 289 (Pubitemid 351168036)
55. McCarty D.M., Fu H., and Monahan P.E. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo Gene Ther 10 2003 2112 2118 (Pubitemid 37536760)
56. Wang Z., Ma H.I., Li J., and Sun L. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo Gene Ther 10 2003 2105 2111 (Pubitemid 37536759)
57. Osman E., Evans V., and Graham I.R. Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice Atherosclerosis 204 2009 121 126